Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cooperating gene mutations in acute myeloid leukemia: a review of the literature
Aline Renneville, Christophe Roumier, Valéria Biggio, et al.
Leukemia (2008) Vol. 22, Iss. 5, pp. 915-931
Closed Access | Times Cited: 357

Showing 1-25 of 357 citing articles:

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix‐Lerosey, Delphine Lequin, Laurence Brugières, et al.
Nature (2008) Vol. 455, Iss. 7215, pp. 967-970
Closed Access | Times Cited: 880
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations
Jih‐Luh Tang, Hsin‐An Hou, Chien‐Yuan Chen, et al.
Blood (2009) Vol. 114, Iss. 26, pp. 5352-5361
Open Access | Times Cited: 328
The role of HOX genes in normal hematopoiesis and acute leukemia
Raed Alharbi, Ruth Pettengell, Hardev Pandha, et al.
Leukemia (2012) Vol. 27, Iss. 5, pp. 1000-1008
Closed Access | Times Cited: 318
Leukaemogenesis: more than mutant genes
Jianjun Chen, Olatoyosi Odenike, Janet D. Rowley
Nature reviews. Cancer (2009) Vol. 10, Iss. 1, pp. 23-36
Open Access | Times Cited: 308
Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome
Annika Dufour, Friederike Schneider, Klaus H. Metzeler, et al.
Journal of Clinical Oncology (2009) Vol. 28, Iss. 4, pp. 570-577
Open Access | Times Cited: 293
250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
Andrew Dunbar, Lukasz P. Gondek, Christine L. O’Keefe, et al.
Cancer Research (2008) Vol. 68, Iss. 24, pp. 10349-10357
Open Access | Times Cited: 292
RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis
Susanne Schnittger, Frank Dicker, Wolfgang Kern, et al.
Blood (2010) Vol. 117, Iss. 8, pp. 2348-2357
Closed Access | Times Cited: 250
Comprehensive mutational profiling of core binding factor acute myeloid leukemia
Nicolas Duployez, Alice Marceau‐Renaut, Nicolas Boissel, et al.
Blood (2016) Vol. 127, Iss. 20, pp. 2451-2459
Open Access | Times Cited: 217
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?
Brunangelo Falini, Maria Paola Martelli, Niccolò Bolli, et al.
Blood (2010) Vol. 117, Iss. 4, pp. 1109-1120
Open Access | Times Cited: 233
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study
Vahid Asnafi, Agnès Buzyn, Sandrine Le Noir, et al.
Blood (2008) Vol. 113, Iss. 17, pp. 3918-3924
Open Access | Times Cited: 225
Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
Nicolas Boissel, Olivier Nibourel, Aline Renneville, et al.
Journal of Clinical Oncology (2010) Vol. 28, Iss. 23, pp. 3717-3723
Closed Access | Times Cited: 217
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group
Phoenix A. Ho, Todd A. Alonzo, Robert B. Gerbing, et al.
Blood (2009) Vol. 113, Iss. 26, pp. 6558-6566
Open Access | Times Cited: 217
Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia
Céline Callens, Séverine Coulon, J. Naudin, et al.
The Journal of Experimental Medicine (2010) Vol. 207, Iss. 4, pp. 731-750
Open Access | Times Cited: 189
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
Ina Radtke, Charles G. Mullighan, Masami Ishii, et al.
Proceedings of the National Academy of Sciences (2009) Vol. 106, Iss. 31, pp. 12944-12949
Open Access | Times Cited: 183
Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy
Eleonora Turrini, Lorenzo Ferruzzi, Carmela Fimognari
Oxidative Medicine and Cellular Longevity (2015) Vol. 2015, pp. 1-19
Open Access | Times Cited: 173
Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions
Samuel Quentin, Wendy Cuccuini, Raphaël Ceccaldi, et al.
Blood (2011) Vol. 117, Iss. 15, pp. e161-e170
Open Access | Times Cited: 172
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML
Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing, et al.
Blood (2010) Vol. 115, Iss. 12, pp. 2372-2379
Open Access | Times Cited: 172
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system
Hsin‐An Hou, Tai‐Chung Huang, Liang‐In Lin, et al.
Blood (2010) Vol. 115, Iss. 25, pp. 5222-5231
Open Access | Times Cited: 170
PHF6 mutations in adult acute myeloid leukemia
Pieter Van Vlierberghe, Jay Patel, Omar Abdel‐Wahab, et al.
Leukemia (2010) Vol. 25, Iss. 1, pp. 130-134
Open Access | Times Cited: 162
MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia
X-N Gao, Jia-Yin Lin, Li Yh, et al.
Oncogene (2011) Vol. 30, Iss. 31, pp. 3416-3428
Closed Access | Times Cited: 160
Differential expression of specific microRNA and their targets in acute myeloid leukemia
Giuseppe Cammarata, Luigi Augugliaro, Domenico Salemi, et al.
American Journal of Hematology (2010) Vol. 85, Iss. 5, pp. 331-339
Open Access | Times Cited: 143
Potent Activity of Ponatinib (AP24534) in Models of FLT3-Driven Acute Myeloid Leukemia and Other Hematologic Malignancies
Joseph M. Gozgit, Matthew J. Wong, Scott Wardwell, et al.
Molecular Cancer Therapeutics (2011) Vol. 10, Iss. 6, pp. 1028-1035
Open Access | Times Cited: 143
Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission
Olivier Nibourel, Olivier Kosmider, Meyling Cheok, et al.
Blood (2010) Vol. 116, Iss. 7, pp. 1132-1135
Open Access | Times Cited: 134
C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice
Yueying Wang, Lijuan Zhao, Chuanfeng Wu, et al.
Proceedings of the National Academy of Sciences (2011) Vol. 108, Iss. 6, pp. 2450-2455
Open Access | Times Cited: 128
Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association
Aline Renneville, Nicolas Boissel, Olivier Nibourel, et al.
Leukemia (2012) Vol. 26, Iss. 6, pp. 1247-1254
Closed Access | Times Cited: 126
Page 1 - Next Page

Scroll to top